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Fetal abnormalities were experimentally produced In
S^■o'lss-Webster mice by Injections of thalidomide, 60 mg/kg
of body weight daily. Deformities were manifested in pro¬
geny of thalidomide injected males and females.
Evidence from this investigation indicates that the
most frequent abnormalities observed v/ere deformities of
the limb, although deformities of the mouth, ear, tail,
and pelvic region were also observed. The frequency and
severity of the abnormalities vrere definitely influenced by
the time at v/hlch the injections were given.
Gross analyses revealed that the greatest number of
deformities were observed in progeny whose mothers had
received injections of thalidomide prior to mating. This
fact was an indication that an accumulation of the teratogen
was acquil’ed before the critical period of paturition.
Histological studies of the testes from slides prepared
by the paraffin method and stained with hematoxylin and eosin
revealed that thalidomide affects the formation of sperms
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The production of fetal abnormalities by the admini¬
stration of tranquillizers and sedatives has provoked much
interest. These drug-induced abnormalities mimic to a great
degree many of the congenital malformations observed in
humans within the present decade.
At a conference in England, Lutwak-Mann (19614.) pre¬
sented data which indicated that men as well as women who
take the tranquillizing drug, thalidomide, could risk de¬
formities in their offsprings. The findings of Lutwak-Mann
stimulated this investigator to experimentally produce
deformities in young mice as a result of both parents having
received injections of thalidomide prior to mating. The
occurrence of these deformities suggested that the abnor¬
malities may have been due to defects in the ova as well as
in the sperms. Evidence from this investigation, however,
revealed no changes in the ova. There were definite indi¬
cations that the malformations of the progeny sired by
thalidomide injected males were due to disturbances in the




Within the present decade, experimental work on labo¬
ratory animals has revealed that a large number of clinical
substances have the power, when administered to pregnant
females, of producing congenital malformations in the off¬
spring. According to Cahen (196lj.), some drugs cross the
placental barrier suad are toxic to the fetus, but do not pro¬
duce malformations in the developing embryos. Other drugs,
however, cause congenital malformation in animals, if given
in massive doses, but are of little teratogenic risk to man.
In a retrospective clinical investigation by McBride
(1962), it was concluded that a supposedly harmless drug,
thalidomide was responsible for fetal abnormalities in patients
who had taken small doses of the drug for a short period
during the early days of pregnancy. Since Somer’s (I960)
routine toxicity test conducted in rats revealed no malfor¬
mations, this conclusion was sharply challenged. As early as
i960, Taussig (1962), reported that the incidence of grossly
deformed infants exhibited at a meeting of pediatricians in
West Germany, could be traced to thalidomide. Her statement
in conjunction with the exhibit attracted little attention.
A few cases of phocomelia, long known as a rare
malformation, were observed in Germany in 1959. The number
of cases of congenital malformations increased. Since the
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latter part of I96I, the number of euch cases seen in the
United Kingdom, Australia and Europe, reached almost epidemic
proportions. These malformations were characterized by
amelia, phocomelia and alimentary abnormalities. The common
factor appeared to have been the administration of thalido¬
mide during early pregnancy. In cases in which the date of
conception was known, the period of sensitivity appeared to
be from the twenty-eighth to the forty-second day, (DiPaolo,
G-atzek and Pickren, 1964),
Among the various malformations, limb deformities are
the most striking (Knapp, Lenz and Nowack, I962, Luers I962,
and Taussig 1962). The most common dysmelio malformations
are: phocomelia, amelia, hypogenesis of the long bones,
syndactyly, polydactyly and microphtalmia, Amomalies of the
heart, duodenal atresia, absence of the common bile duct and
Imperfect anuses have been reported.
Evidence indicating that thalidomide does cause phoco¬
melia and a variety of congenital malformations in the growing
embryo was manifested by the withdrawal of the drug and
failure of new oases to occur. Further proof that thalidomide
produces several teratogenic effects in mice was indicated by
DiPaolo (1963). He made gross analyses of the litters of 62
pregnant strain A mice which had been given thalidomide
orally. According to DiPaola, thalidomide treated animals
having litters with deformities appeared to have fewer fetuses
than did control mothers, which averaged nine fetuses.
ll.
Experiments by Glroud, Tuchraann-Duplesis and Mercler
(1962) were carried out on pregnant animals of three species:
mice9 rabbits» and rats. The mice used were Swiss albinos.
Black and a/HC strains. Daily doses of 125-250 mg/kg of thali¬
domide with food was given from day one to day 14 or day six
to day 14 of pregnancy produced 40-50^ fetal resorption and
five to 11^ gross malformations of the survivors. The most
frequent abnormalities were: harelip, cleft palate, cataracts
and various tail deformities. In the rabbit, daily doses of
125-250 mg/kg mixed in food from day six to day 14 produced
fetal resorptions. Among the surviving fetuses, 30^ exhibited
malformations of the central nervous system, the limbs, and
the axial skeleton. Encephalocele, anencephaly, clubbed feet
and deformities of the spinal column associated with leg-
defects were described.
In the rats, the three strains investigated by GirotJd,
Tuchmann-Duplesis and Mercer (1962) were Wistar, Long-Evans
and August, Thalidomide was added to the food from day one
to 14 or from day six to day 14 of pregnancy in doses ranging
from 250-500 rag/kg. This treatment resulted in 20-40^ fetal
resorption, however, gross malformations were not observed.
Confirmation of the teratogenic effects of thalidomide
was demonstrated by Spencer (1962), in the two Himalayan does
in which five-tenths of thalidomide was given by stomach tube
daily, from day eight to day 14 of pregnancy. The first doe
produced a litter of four, one was still-bom and all the
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litter had marked varus deformities of the hind-limbs. The
second doe was killed and the uterus was found to contain a
second dead fetus with varus hind-limb deformities and marked
foreshortening of the right fore-limb. In both litters the
animals which were born alive died within three days.
Since laboratory investigation on the teratogenic
properties of thalidomide have been undertaken, many curious
and contradicting results have been reported. Hughes,
Delhanty, Jay, Chitham, Playfair and Hopper (1962) established
tissue cultures from two abnormal fetuses and a minimum of
^0 karyotypes per tissue were examined from skin, lung, kid¬
ney and testes in primary culture. There was no evidence of
chromosome mosaicism in the limited number of tissues studied.
The abnormal limb tissue was not studied because at the time
it was not realized that phocomelia could be caused by thali¬
domide .
In an investigation by Luers (1962), thalidomide was
administered to drosophila using the standard Muller-5
technique after feedings of five-tenths per cent solution of
the substance for three days to imagoes. The results indi¬
cated that there was no mutagenic activity of the compound,
neither in sperms, nor in earlier stages of spermatogenesis.
Prom these results, it was concluded that male germ cells of
drosophila were unaffected.
According to Pelisati (1962), thalidomide was given
orally as a one per cent suspension in a oarboxy-methyl-
cellulose solution, 50 fflg/hg of body weight dally to Sprague-
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Dawley rats and rabbits. In the rats the doses were started
the day after coupling and was continued until the twenty-
first day. Malformations were not found in the offsprings
of the rats. Thalidomide was given to five rabbits seven
days after coupling and was continued until the fifteenth
day of pregnancy. One of the five rabbits was killed j’ust
before delivery, the other two that became pregnant gave
birth naturally. Of the 1? fetuses, eight had raisshappened
anterior limbs. The abnormalities consisted of a folding of
the ulna and the radius and hence a shortening of the fore¬
arms, and a hook-like forepaw. In some the big toe was miss¬
ing altogether and in others it was deformed; some haemorrhage
was evident over the deformed carpus. Hydrocephalus was
found in four fetuses and the middle lobe of the lung was
missing in one.
The investigations of King (1962) and Dwomik and
Moore (196^) indicated that thalidomide has a definite effect
on the ossification of bone, particularly of the sternum and
vertebral column. Their work demonstrated that an increase
in the dosage of thalidomide was accompanied by an increase
in the number of sternabra missing or a delay in the ossifi¬
cation of them. Accordingly, Pelisati (1962), noted that
the dosage is extremely significant in determining the extent
of damage and frequency of the malformation.
Gross malformations were observed in fully formed
embryos, both living and dead, as a result of thalidomide
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Injections of doses of 31 to 3^0 mg/kg body weight (DiPaolo,
Gatzek and Pickren, I96I4.), The most frequent anomaly
observed was an open-eye, approximately ten per cent, and
the only mai^ormatlon seen in the control animals was one
case of open-eye. In addition, embryos from treated mothers
had a variety of abnormalities which varied in severity and
laterality, such as enlarged skull on one side, curvature of
the back, kinky tails and a few cases of phocoraella and
micromelia. In the gross autopsy studies, observation of
abnormalities was limited to the bony structures. The
vertebral column was frequently elongated and tortuous. The
rib cage and limbs were shortened and ribs were missing. In
some cases the brain was enlarged. There were no observable
gross abnormalities of the thoracic and abdominal organs.
Woollam (1962a), after successfully obtaining malfor¬
mations in mice, indicated that the most significant single
factor that has to be considered by the experimental tera-
tologlst is when the noxious agent should be administered.
The fetus is sensitive to the effects of such agents only
during a limited period in the early part of pregnancy.
Moreover, there is for each structure in the body a shorter
critical period when it is especially vulunerable. Genersilly,
this period which differs from structure to structure coin¬
cides with the time of greatest mitotic activity.
CHAPTER III
MATERIALS AND METHODS
Ninety-six Swiss-Webster albino mice were obtained
from the Rockland Farms formerly of New City, New York,
presently located at Gllbertsvllle, Pennsylvania. The mice
were eight to nine-weeks old and weighed 2^-30 grams,
A five gram sample of thalidomide, OC-N-phthallmido
glutarimide, was donated for research purposes by Mr. Leon
Lemon. A stock suspension of thalidomide was prepared by
mixing 2^0 mg of thalidomide in 125 cc solvent, a ^Ofo
propylene glycol solution.
The experimental work was xmdertaken in three phases.
In the first phase eight experimental males were given a
series of five intratestlcular injections of thalidomide at
60 rag/kg of body weight per day. Control males received
injections of the suspension medium concurrently with ex¬
perimental mice through the same route. This phase was
designed to produce deformities in progeny fathered by thali¬
domide injected males. The progeny of thalidomide treated
males were designated as Group I,
]n the second phase eight experimental females were
given a series of five subcutaneous peritoneal injections
of thalidomide of 60 mg/kg of body weight per day. Control
females were injected concurrently with experimentals by way
of the same route. The purpose of this phase was to produce
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deformities with thalidomide in the progeny as a result of
the mothers having received thalidomide infections prior to
conception. These progeny were designated as Group II.
In the third phase six pregnant mice were given a
series of five Infections of thalidomide at 60 mg/kg of
body weight for five days postconception. This phase was
designed to produce deformities with thalidomide in the pro¬
geny similar to those which occurred in human infants when
thalidomide was taken by pregnant women during early stages
of pregnancy. The progeny were designated as Group III.
Indication of mating was determined by examination
of females at regular intervals for the presence of a copu¬
lation plug in the vagina. Discovery of the copulation plug
was considered as zero time in the gestation period. In
addition to observing vaginas for copulation plugs, vaginal
smears were made in order to determine the presence of
spermatozoa in the vaginal canal.
A second experiment involving lj.8 additional mice were
imdertaken. The strains of mice, ages, weights, dosages and
routes were the same as utilized in the first experiment.
This experiment was undertaken because mice failed to mate
after two months.
Testes and ovaries from Infected males and females
were prepared for histological studies, according to the




OBSERVATIONS CF THE DEPORI-ED NEW-BORN MICE
Experimental production of abnormalities in new-boms
was successfully accomplished by injections of thalidomide.
Gross analysis was made of the new-born mice and the incidence
and severity of external malformations was determined. Mal¬
formations were manifested in progeny sired by thalidomide
injected males, in progeny of thalidomide injected mothers
prior to conception and in progeny of thalidomide injected
mothers postconception. Macroscopic observations were from
25 litters of the experimental parents and ten litters from
the control parents.
There was a marked death rate among all progeny of
the experimental parents. Approximately of the young
mice were still-bom, while those that were bom alive and
deformed, died shortly after birth or a few hours thereafter.
Thalidomide Induced Malformations
Deformities of the tall.—Gross malformations were
observed in tails of new-boms, both living and dead. The
malformations were manifested as shortened and kinkiness of
the tall. The frequency of this malformation was approxi¬
mated at five-tenths per cent, in contrast to complete
absence of tail deformities in the control mice. Observations
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also revealed complete absence of tails in two mice.
Deformities of the back,—The less frequent abnor¬
mality observed was curvature of the back. This malformation
was observed in youngs which were still-born as well as those
which were born alive. The youngs, so afflicted, made no
attempt to walk or move from positions in which they were
placed.
Deformities of the limbs.—Macroscopic observations
of 25 litters revealed 70^ of limb deformities. Normal for¬
ward movement was prevented due to raalrotation of hind-limbs.
This deformity occurred in the hind-limbs only. In addition
to raalrotation, hind-limbs were shorter than those of the
controls. Shortening of the hind-limbs occurred more fre¬
quently than shortened fore-limbs. In many cases limbs were
shortened only on one side of the body. This applied to
both fore- and hind-limbs. Shortened hind-limbs, in most
cases, were accompanied by twisting of limbs toward the body
or away from it, thereby making normal movement impossible.
Gross analyses of limbs revealed an absence of some
of the toes and syndactyly in some mice, while in others,
club-footedness was observed. A striking malformation was
the attachment of a hind-limb to the abdominal region, an
obvious case of phocomelia. In association with this abnor¬
mal attachment, these limbs were collapsed and tortuous.
Another outstanding anomaly was the attachment of accessory
structures to already deformed limbs.
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Deformities of Pelvic and Head Regions.—The most
outstanding malformation observed in the 2^ litters was an
absence of the pelvic region. Although this was a prominent
malformation, it was observed in only two mice which suc¬
cumbed a few minutes after birth. In two other mice of the
same litter the extremities of the pelvic region were flaccid
and extremely tortuous. There were no such deformities
observed in the control mice.
In 2$% of all young mice deformities of the head
region were observed. The most prevalent deformity in this
region was absences or malformations of the mouths. Mice
having mouth deformities were tmable to suck and consequently
were short-lived. Associated with mouth deformities were
deformities of the ear lobe. In the same young mouse there
was a complete absence of the pinna while in others only a
rudimentary structure was present.
Description of the Control Testis
The testis is an ovoid compound tubular gland sur¬
rounded by a fibrous membrane, the albuginea testis. The
interior is filled with extremely tortuous convoluted semi¬
niferous tubules in which the sperms are formed. A section
through the adult mouse testis (fig. 1) shows the seminiferous
tubules with clusters of interstitial cells compactly scattered
in the angular spaces between the tubules. The interstitial
or Leydig cells are responsible for manufacturing the male
13
hormone which stimulates the production of sperms in the
tubules.
In a mature male mouse the seminiferous tubules are
lined by two kinds of cells, the cells of Sertoli which are
nutrient, supporting cells and the sex or spermatogenic cells
from which sperms develop through the process of prolif -
eration and transformation. A basement membrane surrounds
the tubules to which the cells of Sertoli and spermatogonia
are attached. Separating the Sertoli cells at regular inter¬
vals are the spermatogenic cells.
The cells at the onset of spermatogenesis are the
spermatogonia. These cells undergo a period of growth during
which they increase in size and the nuclear content becomes
more distinct. VThile in this growth phase the cells are
gradually shifted toward the lumen of the tubules. The cells
at the termination of the period of growth are called primary
spermatocytes. These cells enter a period of maturation
dTiring which the primary spermatocytes divide into two cells,
the secondary spermatocytes. These cells exist only for a
short time and then divide into two cells the spermatids.
The spermatids represent the completion of maturation and are
transformed into spermatozoa. The heads change into long
spear-shaped bodies while the tails become slender and elon¬
gated. The sperms then leave the wall of the tubule and
pass into the lumen from which they propel themselves to the
vas deferens.
Ill-
Description of the Thalidomide
Injected Testis
Beneath the fibrous albuginea testis many of the
tubules appeared loosely suspended due to the absence of inter¬
stitial cells. Only fragments of these cells were observed
between the tubules (fig. 2), In addition to the tubules
being loosely suspended, dissolution or partial dissolution
of the basement membrane of many of the tubules was observed
(fig. 3)- Only viscous appearing strands wore present.
In tubules where the basement membrane persisted,
large irregularly shaped cells were loosely attached and had
the appearance of spermatogonia (fig. 1|.). The second and
third tiers of cells, the primary spermatocytes, are smaller
and more irregularly shaped. The cells nearest the lumen are
diffused and exhibited a variety of shapes, from globose to
stellate-like. In the same tubules, the lumen was occluded
with a granular-like debris (fig. $), but was completely
void of sperms (fig. 6).
The tubules in which partial dissolution of the base¬
ment membrane was evident, the cells appeared loosely sus¬
pended with little or no intercellular cement between them
(fig, 7). These diffused cells were of two definite cell
types, spermatogonia and primary spermatocytes (fig. 8).
In other tubules in which complete dissolution
appeared to have occurred, the cells that lined the tubule,
both Sertoli and spermatogonia appeared to have been
dissolved (fig. 9). Only the cells near and in the lumen
were distinct and did not have the appearance of maturing
germ cells. In no instance were sperms fovmd in the tubules.
In tubules in which the basement appeared unaffected,
only matrix-like material was observed (fig. 9). Diffused
large cells filled the remainder of the tubule. In addition
to these large cells which filled the lumen of the tubules,
a section through the epididyraus revealed the presence of
the same cell shapes and varied sized cells instead of sperms
as in the control testis.
In the lumen of tubules, in which maturation was com¬
plete, sperms of various shapes, globose, ellipsoid and
stellate were found. Associated with these diverse shapes of
sperms a fibrous-like debris was present (fig. 10),
Tubules in which both basement membrane and intercel¬
lular cement had been retained, the cells were only three to
four tiers thick, which left a large lumen void of any cells.
CHAPTER V
DISCUSSION
The results obtained in this investigation clearly
indicate that injections of thalidomide cause abnormalities
of varying degrees in Swiss-Webster albino mice. Although
deformities of the limb were most frequent, deformities of
the mouth, ears, tails and pelvic regions were also observed.
Studies on embryonic development and teratology have
revealed that there are definite and well defined stages of
embryonic development during which teratogens and noxious
agents will change the fate of particular parts. According
to Woollam (I962 a), the fetus is sensitive to thalidomide
only during the "critical period" of parturition. Further-
more, the susceptible periods vary from organ to organ. They
frequently coincide with the first visible appearance of a
particular prlmordium, however, the sensitive period may pre¬
cede the time at which a prlmordium can first be recognized
as a morphological entity (Landauer, 1953)*
Woollam stated that the incidence of malformation of
particular structures vary with the amount of dosage and time
of administration. In another investigation by Woollam
(1962 b) he observed that when the dosage was doubled, dif¬
ficulties in parturition were experienced and the frequency
of malformations increased.
The greatest number of abnormalities were observed in
new-born mice whose mothers received injections of thalidomide
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prior to pregnancy. This fact tends to indicate that a
sufficient accumulation of thalidomide was acquired before
the critical period was reached and the deleterious effect
of this noxious agent was manifested by a high frequency of
deformities and a marked death rate.
The high death rate may be explained on the basis
that the dosage of the teratogen might have reached the toxic
level before the level of teratogenesis was accomplished.
Accordingly, Cahen (1961}.) stated that many drugs which are
toxic do not produce malformations regardless of the amount
of the dosage. This fact would accoxmt for many of the mice
in this investigation being still-bom.
Since abnormalities of the limbs were more frequent
in the hind-limbs than in the fore-limbs, it appears that the
thalidomide exerted its effect during the susceptibility stage
of these structures, DiPaola (1963) proposed a possible ex¬
planation of this occurrence by stating that the hind-limbs
are slower to appear than the fore-limbs, thereby, rendering
them more susceptible to thalidomide.
According to Landauer (19^3)# micromelia is presumably
the result of a disturbance in the growth of long bones. It
seems likely that the abnormalities of the appendicular
skeleton are likewise the result of a failure of the constit¬
uent cartilaginous prlmordia to grow normally. In particular
circumstances, disharmonies and dislocations of growth result
in gross malformations such as syndactylism and bending of
the limbs and tall.
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The experimental production of abnormalities appears
to depend directly on the amovint of the dosage and the time
at which thalidomide is administered. The production of
deformities in progeny of thalidomide injected males is an
indication that males as well as females can risk deformities
in their offspring after taking dosages of the teratogen.
Observation of the testes of these thalidomide injected males
revealed some interesting results.
This phase of the investigation involving observations
of thalidomide injected testes clearly revealed a deleterious
effect on spermatogenesis. Partial or complete dissolution
of the basement membrane of the tubules may have been due to
thalidomide which may have had an affinity for its lipo¬
protein components, thereby causing a breakdown of the mem¬
brane, In the tubules in which the basement membrane
persisted the large irregularly shaped cells appeared to have
been spermatogonia. The presence of these cells throughout
the tubule may be a possible Indication that the process of
spermatogenesis had not proceeded beyond the level of the
spermatogonium. Therefore it may be that thalidomide caused
developmental arrest of the sex cells.
The absence of intercellular cement may have been due
to the action of thalidomide upon the constituent, hyaluronic
acid, or it may have caused a hypersecretion of the enzyme
hyaluronidase, thus causing an imbalance between en»yme and
substrate. If such an abnormal situation occurred the
19
hyaluronldase would possibly have digested away the inter¬
cellular matrix between the cells, which left them free as
was observed. It may also be that thalidomide or one of its
metabolites may have acted as a solvent for the hyaluronic
acid of the intercellular matrix and of the lipo-proteins
of the basement membrane of the tubule.
Destruction of the Sertoli cells may also account for
developmental arrest and malformation of sperms, since they
are nutritive and supporting in nature. The absence of
interstitial or Leydig cells would account for the failure
of conception to have occurred in the mice during a two-month
period after administration of thalidomide. The cells of
Leydig are believed to produce the male hormone which stimu¬
late the production of sperms. In the absence of this
hormonal influence the sperms could not have formed. The
presence of a small number of cells of Leydig may not have
produced enough androgen so that the spermatids could be
transformed into normal sperms.
CHA.PTER VI
SUMMARY AND CONCLUSIONS
The reaction of the developing organism to thalidomide
depends upon the following factors:1.the stage at which it is subjected to thalidomide,
2* the nature of this teratogenic substance,
3. the length of time it is exposed, and
4. the physiological condition of the developing
organism.
Thalidomide affects the formation of the sperms by:
1. destroying the cells of Leydig, thereby preventing
the formation of sperms,
2. causing developmental arrest of spermatogonia,
3. destroying the intercellular matrix and
4. destroying the cells of Sertoli.
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OPIATE I





. Transverse section through a control testis showing
tubules (t) with interstitial cells (ic). x970.
, Transverse section through the seminiferous tubule
of a thalidomide injected testis showing dissolution
and destruction of the basement membrane (bm) x970.
 
OPIATE II





. Transverse section through a tubule of a thalidomide
injected testis showing large irregularly shaped
(isc) cells loosely attached to the basement mem¬
brane (bra). x970.
. Transverse section through a tubule of a thalidomide









. Transverse section through a tubule of a thalidomide
injected testis showing lumen containing matrix-
like debris (mid). x970.
. Transverse section through a tubule of a thalidomide
injected testis showing dissolution of the basement









. Transverse section through a tubule of a thalidomide
injected testis showing partial dissolution of the
basement membrane (bm) and breakdown of inter¬
cellular cement (ic). x970.
. Transverse section through a tubule of a thalidomide
injected testis showing spermatogonia (s) along the
basement membrane (bm) and primary spermatocytes
(psp) loosely diffused near lumen (1), x970.
 
(Explanation of Figures)
Pig. 9. Transverse section through a tubule of a thalidomide
injected testis showing dissolution of both
spermatogonia (s) and cells of Sertoli (cS). Large
irregularly shaped cells fill the lumen (isc).
x970.
Pig, 10. Transverse section through a tubule of a thalido¬
mide injected testis in which maturation appeared
to be complete. Sperms of various shapes are
located near the lumen (s), A fibrous-like debris
fill the lumen (de), x970.
*PLATE V
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